FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386260925> ?p ?o ?g. }

• W4386260925 endingPage "S194" @default.
• W4386260925 startingPage "S193" @default.
• W4386260925 abstract "Abstract Introduction The conventional treatment for deep 2nd and 3rd degree burn injuries has been excision and grafting, which was first described approximately 80 years ago. New techniques and technology in the field of burn surgery that facilitate “minimally invasive” donor site reduction include bromelain enzymatic debridement and autologous skin cell sprays (ASCS). Each of these techniques independently have been shown to decrease the need of autografting and reduce the donor site size. However, the use of both methods together was not possible until recently. The authors hypothesize that bromelain enzymatic debridement plus ASCS will result in donor site reduction compared to conventional excision and grafting. Methods A single institution retrospective review of patients who underwent treatment of deep 2nd and 3rd degree burns was performed. The patients were stratified into those that received conventional excision and autografting (CONTROL group), and those that received bromelain enzymatic debridement with autologous skin cell spray with or without a split thickness skin graft (TREATMENT group). Data collection included demographics, injury characteristics, length of stay (LOS)/%TBSA. Total surface area treated with ASCS, autograft, and donor site size was tabulated. A ratio of donor site to total area treated was calculated and compared to determine relative reduction in donor site size. Data was reported in medians+IQR and comparisons were done with a Mann Whitney test. Results Twenty-eight study patients were included over 18 months, 15 CONTROLS and 13 TREATMENT patients. Burns size was 1789 cm2 (IQR: 450, 2434) and 1463cm2 (IQR: 699, 2740.5) in the CONTROLS and TREATMENT groups, respectively. There were no differences in age and sex. The total area grafted and/or treated with ASCS was 1342 cm2 (IQR: 824, 2535) in the CONTROLS and 1404 cm2 (IQR: 1021.5, 2430.5) in the TREATMENT group (p=0.4354). The donor site area to total treatment area ratio for CONTROLS was 0.273 (IQR:0.18,0.47) while the TREATMENT group was 0.082 (IQR:0.039,0.241) (p=0.013). The O/E ratio for LOS was 1.35 days/%TBSA for the CONTROLS and 1.06 for the TREATMENT group (p= 0.2). No significantly differences were detected in comorbidities between groups. Each group had 1 unplanned readmission but no graft loss. There were no mortalities. Conclusions Bromelain based enzymatic debridement can be successfully utilized with ASCS to perform a “minimally invasive” skin graft. These patients received relatively smaller donor sites and showed a trend for lower LOS. Just as with all surgical therapies, appropriate patient selection and burn characteristics are imperative when utilizing minimally invasive burn surgery. Further larger scale studies are needed to adjust for confounders and determine the individual and synergistic effects of the component novel therapies. Applicability of Research to Practice Donor site reduction improves care paradigms" @default.
• W4386260925 created "2023-08-30" @default.
• W4386260925 creator A5012732120 @default.
• W4386260925 creator A5028258982 @default.
• W4386260925 creator A5031302291 @default.
• W4386260925 creator A5040034766 @default.
• W4386260925 creator A5044610689 @default.
• W4386260925 creator A5049607498 @default.
• W4386260925 creator A5063988136 @default.
• W4386260925 creator A5070118845 @default.
• W4386260925 creator A5085376835 @default.
• W4386260925 date "2023-05-01" @default.
• W4386260925 modified "2023-10-16" @default.
• W4386260925 title "299 Donor Site Reduction with Combined Use of Bromelain Enzymatic Debridement and Autologous Skin Cell Suspension" @default.
• W4386260925 doi "https://doi.org/10.1093/jbcr/irad045.274" @default.
• W4386260925 hasPublicationYear "2023" @default.
• W4386260925 type Work @default.
• W4386260925 citedByCount "0" @default.
• W4386260925 crossrefType "journal-article" @default.
• W4386260925 hasAuthorship W4386260925A5012732120 @default.
• W4386260925 hasAuthorship W4386260925A5028258982 @default.
• W4386260925 hasAuthorship W4386260925A5031302291 @default.
• W4386260925 hasAuthorship W4386260925A5040034766 @default.
• W4386260925 hasAuthorship W4386260925A5044610689 @default.
• W4386260925 hasAuthorship W4386260925A5049607498 @default.
• W4386260925 hasAuthorship W4386260925A5063988136 @default.
• W4386260925 hasAuthorship W4386260925A5070118845 @default.
• W4386260925 hasAuthorship W4386260925A5085376835 @default.
• W4386260925 hasBestOaLocation W43862609251 @default.
• W4386260925 hasConcept C111335779 @default.
• W4386260925 hasConcept C141071460 @default.
• W4386260925 hasConcept C167135981 @default.
• W4386260925 hasConcept C181199279 @default.
• W4386260925 hasConcept C185592680 @default.
• W4386260925 hasConcept C2524010 @default.
• W4386260925 hasConcept C2776714187 @default.
• W4386260925 hasConcept C2777334355 @default.
• W4386260925 hasConcept C2777438270 @default.
• W4386260925 hasConcept C2777750529 @default.
• W4386260925 hasConcept C2911091166 @default.
• W4386260925 hasConcept C33923547 @default.
• W4386260925 hasConcept C55493867 @default.
• W4386260925 hasConcept C71924100 @default.
• W4386260925 hasConceptScore W4386260925C111335779 @default.
• W4386260925 hasConceptScore W4386260925C141071460 @default.
• W4386260925 hasConceptScore W4386260925C167135981 @default.
• W4386260925 hasConceptScore W4386260925C181199279 @default.
• W4386260925 hasConceptScore W4386260925C185592680 @default.
• W4386260925 hasConceptScore W4386260925C2524010 @default.
• W4386260925 hasConceptScore W4386260925C2776714187 @default.
• W4386260925 hasConceptScore W4386260925C2777334355 @default.
• W4386260925 hasConceptScore W4386260925C2777438270 @default.
• W4386260925 hasConceptScore W4386260925C2777750529 @default.
• W4386260925 hasConceptScore W4386260925C2911091166 @default.
• W4386260925 hasConceptScore W4386260925C33923547 @default.
• W4386260925 hasConceptScore W4386260925C55493867 @default.
• W4386260925 hasConceptScore W4386260925C71924100 @default.
• W4386260925 hasIssue "Supplement_2" @default.
• W4386260925 hasLocation W43862609251 @default.
• W4386260925 hasOpenAccess W4386260925 @default.
• W4386260925 hasPrimaryLocation W43862609251 @default.
• W4386260925 hasRelatedWork W1969520943 @default.
• W4386260925 hasRelatedWork W1994127247 @default.
• W4386260925 hasRelatedWork W2369162477 @default.
• W4386260925 hasRelatedWork W2392208455 @default.
• W4386260925 hasRelatedWork W2905015289 @default.
• W4386260925 hasRelatedWork W2985113304 @default.
• W4386260925 hasRelatedWork W3007350405 @default.
• W4386260925 hasRelatedWork W3029869006 @default.
• W4386260925 hasRelatedWork W3030907015 @default.
• W4386260925 hasRelatedWork W62711790 @default.
• W4386260925 hasVolume "44" @default.
• W4386260925 isParatext "false" @default.
• W4386260925 isRetracted "false" @default.
• W4386260925 workType "article" @default.